NO992384L - Multivalente salter av pyridostigmin og relaterte forbindelser - Google Patents
Multivalente salter av pyridostigmin og relaterte forbindelserInfo
- Publication number
- NO992384L NO992384L NO992384A NO992384A NO992384L NO 992384 L NO992384 L NO 992384L NO 992384 A NO992384 A NO 992384A NO 992384 A NO992384 A NO 992384A NO 992384 L NO992384 L NO 992384L
- Authority
- NO
- Norway
- Prior art keywords
- anions
- modifications
- ring
- pyridostigmine
- related compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3118696P | 1996-11-19 | 1996-11-19 | |
| PCT/US1997/020509 WO1998022458A1 (en) | 1996-11-19 | 1997-11-10 | Multivalent salts of pyridostigmine and related compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO992384D0 NO992384D0 (no) | 1999-05-18 |
| NO992384L true NO992384L (no) | 1999-07-16 |
Family
ID=21858083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO992384A NO992384L (no) | 1996-11-19 | 1999-05-18 | Multivalente salter av pyridostigmin og relaterte forbindelser |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6211201B1 (xx) |
| EP (1) | EP0941224A4 (xx) |
| JP (1) | JP2001505561A (xx) |
| KR (1) | KR20000069028A (xx) |
| CN (1) | CN1237969A (xx) |
| AU (1) | AU717740B2 (xx) |
| BR (1) | BR9713112A (xx) |
| CA (1) | CA2271786A1 (xx) |
| CZ (1) | CZ172799A3 (xx) |
| HU (1) | HUP9904040A3 (xx) |
| IL (1) | IL129619A0 (xx) |
| NO (1) | NO992384L (xx) |
| NZ (1) | NZ335419A (xx) |
| PL (1) | PL333414A1 (xx) |
| SI (1) | SI20018A (xx) |
| SK (1) | SK64399A3 (xx) |
| WO (1) | WO1998022458A1 (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002092003A2 (en) * | 2001-05-11 | 2002-11-21 | Bacaner Marvin B | Novel therapeutical quaternary ammonium compositions |
| KR20050088992A (ko) * | 2002-10-07 | 2005-09-07 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 아난드아미드 가수분해 차단을 통한 불안감의 조절 |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| CN106061984A (zh) | 2014-02-13 | 2016-10-26 | 配体药物公司 | 前药化合物及其用途 |
| EP3164136A4 (en) | 2014-07-02 | 2018-04-04 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
| CN107854428A (zh) * | 2016-12-20 | 2018-03-30 | 成都医学院 | 一种溴吡斯的明糖浆剂及其制备方法 |
| CA3087932A1 (en) | 2018-01-09 | 2019-07-18 | Ligand Pharmaceuticals, Inc. | Acetal compounds and therapeutic uses thereof |
| CN113277961B (zh) * | 2021-04-09 | 2023-05-09 | 深圳市新浩瑞医药科技有限公司 | 一种溴新斯的明的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4692530A (en) * | 1967-03-07 | 1987-09-08 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4686293A (en) * | 1967-05-29 | 1987-08-11 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4672120A (en) * | 1967-07-03 | 1987-06-09 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4246416A (en) * | 1967-12-01 | 1981-01-20 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4677222A (en) * | 1968-01-22 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Army | Ketobenzylcarbamates |
| US5534623A (en) * | 1993-01-21 | 1996-07-09 | Du Pont (Uk) Limited | Process for preparing a polyunsaturated diazonium compounds |
-
1997
- 1997-11-10 AU AU62367/98A patent/AU717740B2/en not_active Ceased
- 1997-11-10 KR KR1019997004410A patent/KR20000069028A/ko not_active Application Discontinuation
- 1997-11-10 SI SI9720075A patent/SI20018A/sl not_active IP Right Cessation
- 1997-11-10 HU HU9904040A patent/HUP9904040A3/hu unknown
- 1997-11-10 NZ NZ335419A patent/NZ335419A/xx not_active IP Right Cessation
- 1997-11-10 CA CA002271786A patent/CA2271786A1/en not_active Abandoned
- 1997-11-10 CZ CZ991727A patent/CZ172799A3/cs unknown
- 1997-11-10 IL IL12961997A patent/IL129619A0/xx unknown
- 1997-11-10 SK SK643-99A patent/SK64399A3/sk unknown
- 1997-11-10 PL PL97333414A patent/PL333414A1/xx unknown
- 1997-11-10 JP JP52371598A patent/JP2001505561A/ja active Pending
- 1997-11-10 CN CN97199841A patent/CN1237969A/zh active Pending
- 1997-11-10 EP EP97954835A patent/EP0941224A4/en not_active Withdrawn
- 1997-11-10 US US09/308,723 patent/US6211201B1/en not_active Expired - Lifetime
- 1997-11-10 WO PCT/US1997/020509 patent/WO1998022458A1/en not_active Application Discontinuation
- 1997-11-10 BR BR9713112-1A patent/BR9713112A/pt not_active IP Right Cessation
-
1999
- 1999-05-18 NO NO992384A patent/NO992384L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0941224A1 (en) | 1999-09-15 |
| NO992384D0 (no) | 1999-05-18 |
| CA2271786A1 (en) | 1998-05-28 |
| SK64399A3 (en) | 2000-05-16 |
| KR20000069028A (ko) | 2000-11-25 |
| HUP9904040A3 (en) | 2000-09-28 |
| CN1237969A (zh) | 1999-12-08 |
| US6211201B1 (en) | 2001-04-03 |
| JP2001505561A (ja) | 2001-04-24 |
| PL333414A1 (en) | 1999-12-06 |
| CZ172799A3 (cs) | 1999-10-13 |
| NZ335419A (en) | 2000-05-26 |
| WO1998022458A1 (en) | 1998-05-28 |
| BR9713112A (pt) | 2000-04-11 |
| SI20018A (sl) | 2000-02-29 |
| AU6236798A (en) | 1998-06-10 |
| HUP9904040A2 (hu) | 2000-05-28 |
| AU717740B2 (en) | 2000-03-30 |
| EP0941224A4 (en) | 2000-01-12 |
| IL129619A0 (en) | 2000-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0012590A (pt) | Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central | |
| NO992384L (no) | Multivalente salter av pyridostigmin og relaterte forbindelser | |
| NO20020211D0 (no) | Anvendelse av deskarboksyloratadin for fremstilling av et farmasöytisk preparat for behandling av medisinske tilstander | |
| BR9714677A (pt) | "enantiÈmeros 3-piridila e seu uso como analgésicos" | |
| NO20006604L (no) | Fremgangsmåter og transdermale sammensetninger for lindring av smerte | |
| BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
| Horita et al. | The interaction between reversible and irreversible monoamine oxidase inhibitors | |
| NO307570B1 (no) | Inklusjonskomplekser oppnådd fra nimesulidalkali- og nimesulidjordalkalisalter og cyklodekstriner eller cyklodekstrinderivater, samt farmasøytisk preparat inneholdende nevnte inklusjonskompleks og fremgangsmåte for å fremstille samme | |
| DE3780819D1 (de) | Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen. | |
| NZ507303A (en) | Quinolin-4-yl derivatives II and their use in treating neurodegenerative disease | |
| NO892152L (no) | Kondenserte diazepinoner, fremstilling derav og legemidler som inneholder dem. | |
| KR980000445A (ko) | 인식 증강 방법 | |
| WO1998022458B1 (en) | Multivalent salts of pyridostigmine and related compounds | |
| CA2394471A1 (en) | External preparation for treating pruritus | |
| EP1152760A4 (en) | USE OF 4-AMINO PYRIDINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES | |
| NO985063L (no) | Pyridyl- og pyrimidyl-piperaziner i behandling av substansmisbruks forstyrr | |
| MX9710093A (es) | Uso de aminas alilicas. | |
| SE8804640D0 (sv) | Medicament comprising cyclolinopeptide a | |
| Burkhart et al. | Decreased efficacy of topical anesthetic creams in presence of benzoyl peroxide | |
| Uchida | Clinical efficacy of topical lomefloxacin(NY-198) in bacterial infections of the external eye. | |
| Lewis et al. | Use of convalescent serum in the prevention of chickenpox | |
| RU94044455A (ru) | Средство для усиления функции макрофага и лечения человека с ослабленным иммунитетом | |
| Burningham et al. | A clinical update on fungal disease of human skin | |
| Kaviani et al. | Trial comparing metronidazole and furazolidone (omeprazole, tetracycline, bismuth plus metronidazole vs furazolidone) for eradication of Helicobacter pylori in Iranian peptic ulcer disease patients | |
| Emad et al. | Comparison of topical and oral Ketoconazole in the treatment of intractable Seborrheic dermatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |